Skip to content

Myocardial mass determination of the different coronary territories by FFRct and invasive measurement of absolute coronary blood flow. A clinical Registry.

Myocardial mass determination of the different coronary territories by FFRct and invasive measurement of absolute coronary blood flow. A clinical Registry. - MyoMass study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44459
Enrollment
40
Registered
2018-03-16
Start date
2018-06-20
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary disease

Interventions

None listed

Sponsors

Catharina-ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Presence of multivessel coronary disease with an indication for multivessel FFR and/or PCI or Patients with single vessel disease scheduled for FFR/PCI of that single coronary artery 2) Availability of a coronary CT scan performed prior to the scheduled invasive investigation. The time difference between the CT scan and the invasive exam should be less than 3 months. 3) Focal lesions only 4) Normal left ventricular function 5) Age

Exclusion criteria

Exclusion criteria: 1) Inability to give informed consent 2) Diffuse coronary disease 3) Tortuous or calcified arteries interfering with reliable invasive FFR assessment 4) Previous myocardial infarction or ejection fraction less than 60% by echocardiography or ventriculography or less than 50% by nuclear methods 5) Atrial fibrillation interfering with high quality coronary CT scanning 6) Age > 75 years 7) Other contra-indications for CT scanning 8) Pregnancy or admired pregnancy in the future 9) Left main stenosis

Design outcomes

Primary

MeasureTime frame
Het is rondom coronaire interventies zoals PCI of CABG van klinisch belang om het risico voor de patient in te schatten. Er is tot op heden geen non-invasieve methode beschikbaar om het gebied van necrose in te schatten na een myocardinfarct of procedure. Vooral bij een percutane coronaire interventie (PCI) zou het erg waardevol zijn om informatie te hebben omtrend de absolute en relatieve myocardiale massa distaal van het 'interventie gebied'. Deze informatie kan helpen bij de risico inschatting en tevens bij het bepalen van de beste revascularisatie methode bij meervatslijden. Het primaire onderzoeksdoel is dan ook het quantificeren van de hartmassa en bloedflow per coronairgebied.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)